Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma

Cancer Letters

Volumn 224, Issue 2, 2005, Pages 253-261

  Kim, Myung Jin ^a   Lim, Koo Young ^a   Kim, Jong Won ^a   Nam, Il Woo ^a   Lee, Jong Ho ^a   Myoung, Hoon ^a  

^a Seoul National University   (South Korea)

Author keywords

Oral squamous cell carcinoma; Prognostic indicator; Survivin; TNM stage

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLINE; CYTOKERATIN; SURVIVIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KOREA; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; HUMANS; KERATINS; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 19444369549     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.009     Document Type: Article

References (43)

1. S. Silverman Jr., and M. Gorsky Epidemiologic and demographic update in oral cancer: California and national data - 1973 to 1985 J. Am. Dent. Assoc. 120 5 1990 495 499
2. P. Pisani, D.M. Parkin, F. Bray, and J. Ferlay Estimates of the worldwide mortality from 25 cancers in 1990 Int. J. Cancer 83 1999 18 29
3. Annual Report of the Korea Central Cancer Registry (Based on Registered Data from 139 Hospitals), 2002.
4. H. Schliephake Prognostic relevance of molecular markers of oral cancer - a review Int. J. Oral Maxillofac. Surg. 32 2003 233 245
5. P.L. Friedlander The use of genetic markers in the clinical care of patients with head and neck cancer Arch. Otolaryngol. Head Neck Surg. 129 2003 363 366
6. E. Yamamoto, A. Miyakawa, and G. Kohama Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity Head Neck Surg. 6 1984 938 947
7. T.R. Helliwell Molecular markers of metastasis in squamous carcinomas J. Pathol. 194 2001 289 293
8. M.A. Kim, H.S. Lee, H.K. Yang, and W.H. Him Cytokeratin expression profile in gastric carcinomas Hum. Pathol. 35 2004 576 581
9. Y. Sakao, S. Tomimitsu, Y. Takeda, M. Natsuaki, and T. Itoh Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma Eur. J. Cardiothorac. Surg. 25 2004 520 522
10. H. Shimada, Y. Nabeya, S. Okazumi, H. Matsubara, T. Shiratori, and Y. Gunji Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma Surgery 133 2003 486 494
11. W.L. Zhao, M.E. Daneshpouy, N. Mounier, J. Briere, C. Leboeuf, and L.F. Plassa Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma Blood 103 2004 695 697
12. I.D. Fleming AJCC Cancer Staging Handbook fifth ed. 1998 Lippincott Williams and Wilkins Baltimore, MD pp. 29-34
13. Y. Okada, Y. Fujiwara, H. Yamamoto, Y. Sugita, T. Yasuda, and Y. Doki Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay Cancer 92 2001 2056 2064
14. L. O'Driscoll, R. Linehan, M. Kennedy, D. Cronin, R. Purcell, and S. Glynn Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer Cancer Lett. 201 2003 225 236
15. L.A. Liotta, C.N. Rao, and S.H. Barsky Tumor invasion and the extracellular matrix Lab. Invest. 49 1983 636 649
16. K. Kubota, H. Nakanishi, N. Hiki, N. Shimizu, E. Tsuji, and H. Yamaguchi Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry Int. J. Cancer 105 2003 136 143
17. H. Nakanishi, Y. Kodera, A. Torii, T. Hirai, Y. Yamamura, and T. Kato Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction Jpn J. Cancer Res. 88 1997 687 692
18. Y. Kodera, H. Nakanishi, Y. Yamamura, Y. Shimizu, A. Torii, and T. Hirai Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology Int. J. Cancer 79 1998 429 433
19. M. Mori, K. Mimori, H. Ueo, K. Tsuji, T. Shiraishi, and G.F. Barnard Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas J. Clin. Oncol. 16 1998 128 132
20. K. Mafune, K.S. Saini, T.S. Ravikumar, L.B. Chen, G.D. Steele Jr., and P. Thomas Differences in messenger RNA expression of carcinoembryonic antigen in surgical specimens of colorectal carcinoma Tumour Biol. 13 1992 330 337
21. D.C. Altieri, P.C. Marchisio, and C. Marchisio Survivin apoptosis: an interloper between cell death and cell proliferation in cancer Lab. Invest. 79 1999 1327 1333 (Review)
22. D.S. O'Connor, D. Grossman, J. Plescia, F. Li, H. Zhang, and A. Villa Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin Proc. Natl Acad. Sci. USA 97 2000 13103 13107
23. E.C. LaCasse, S. Baird, R.G. Korneluk, and A.E. MacKenzie The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 17 1998 3247 3259 (Review)
24. T. Ito, K. Shiraki, K. Sugimoto, T. Yamanaka, K. Fujikawa, and M. Ito Survivin promotes cell proliferation in human hepatocellular carcinoma Hepatology 31 2000 1080 1085
25. H. Kawasaki, D.C. Altieri, C.D. Lu, M. Toyoda, T. Tenjo, and N. Tanigawa Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res. 58 1998 5071 5074
26. C. Adida, C. Haioun, P. Gaulard, E. Lepage, P. Morel, and J. Briere Prognostic significance of survivin expression in diffuse large B-cell lymphomas Blood 96 2000 1921 1925
27. H.S. Swana, D. Grossman, J.N. Anthony, R.M. Weiss, and D.C. Altieri Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer N. Engl. J. Med. 341 1999 452 453
28. S.M. Kennedy, L. O'Driscoll, R. Purcell, N. Fitz-Simons, E.W. McDermott, and A.D. Hill Prognostic importance of survivin in breast cancer Br. J. Cancer 88 2003 1077 1083
29. P. Grabowski, T. Kuhnel, F. Muhr-Wilkenshoff, B. Heine, H. Stein, and M. Hopfner Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma Br. J. Cancer 88 2003 115 119
30. K. Trieb, R. Lehner, T. Stulnig, I. Sulzbacher, and K.R. Shroyer Survivin expression in human osteosarcoma is a marker for survival Eur. J. Surg. Oncol. 29 2003 379 382
31. I. Tamm, S. Richter, D. Oltersdorf, U. Creutzig, J. Harbott, and F. Scholz High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia Clin. Cancer Res. 10 2004 3737 3744
32. L. Lo Muzio, S. Staibano, G. Pannone, M.D. Mignogna, A. Mariggio, and G. Salvatore Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma Exp. Mol. Pathol. 70 2001 249 254
33. Y. Kajiwara, F. Yamasaki, S. Hama, K. Yahara, H. Yoshioka, and K. Sugiyama Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis Cancer 97 2003 1077 1083
34. K. Miyachi, K. Sasaki, S. Onodera, T. Taguchi, M. Nagamachi, H. Kaneko, and M. Sunagawa Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer Gastric Cancer 6 2003 217 224
35. G.J. Liefers, A.M. Cleton-Jansen, C.J. van de Velde, J. Hermans, J.H. van Krieken, C.J. Cornelisse, and R.A. Tollenaar Micrometastases and survival in stage II colorectal cancer N. Engl. J. Med. 339 1998 223 228
36. Y. Miyake, H. Yamamoto, Y. Fujiwara, M. Ohue, Y. Sugita, and N. Tomita Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping Clin. Cancer Res. 7 2001 1350 1357
37. F. Kijima, S. Natsugoe, S. Takao, K. Aridome, M. Baba, and M. Yoshifumi Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma Oncology 58 2000 38 44
38. T. Hashimoto, Y. Kobayashi, Y. Ishikawa, S. Tsuchiya, S. Okumura, and K. Nakagawa Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases Cancer Res. 60 2000 6472 6478
39. Z. Kelman PCNA: structure, functions and interactions Oncogene 14 1997 629 640
40. A.S. Jones, N.J. Roland, A.W. Caslin, T.G. Cooke, L.D. Cooke, and G. Forster A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck J. Laryngol. Otol. 108 1994 859 864
41. M. Liu, G. Lawson, M. Delos, J. Jamart, B. Chatelain, and M. Remacle Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx Eur. Arch. Otorhinolaryngol. 260 2003 28 34
42. A. Franchi, O. Gallo, V. Boddi, and M. Santucci Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination Clin. Cancer Res. 2 1996 1801 1808
43. C. Sittel, S. Ruiz, P. Volling, H.M. Kvasnicka, M. Jungehulsing, and H.E. Eckel Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity Oral Oncol. 35 1999 583 589